Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


May 24, 2015 7:30 PM ET

Pharmaceuticals

Company Overview of BEXEL Pharmaceuticals, Inc.

Executive Profile

Subramaniam Sriram Ph.D., M.D.

AgeTotal Calculated CompensationThis person is connected to 0 Board Members in 0 different organizations across 1 different industries.

----

Background

Mr. Subramaniam Sriram, Ph.D., M.D., co-founded BEXEL Pharmaceuticals, Inc. in 2002. Mr. Sriram is a Co-Founder of BEXEL Biotechnology Inc. and has been its Director since 1998. He is an Internationally recognized Neurologist and Immunologist. He co-founded and served as Chairman of Scientific Advisory Board of Calyx Therapeutics Inc. from 1997 to 2002. Mr. Sriram has been Director of Multiple Sclerosis Center of Vanderbilt University since 1996. He served as William ...

Corporate Headquarters

32990 Alvarado Niles Road
Union City, California 94587

United States

Phone: 510-324-0015
Fax: 510-324-0058

Board Members Memberships

There is no Board Members Memberships data available.

Education

MD
University of Madras

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BEXEL Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.